- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Eosinophilic Disease market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500 cells/μl crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.
This report is a detailed and comprehensive analysis for global Eosinophilic Disease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Eosinophilic Disease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Eosinophilic Disease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Eosinophilic Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Eosinophilic Disease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Eosinophilic Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Eosinophilic Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca and GSK plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Eosinophilic Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Corticosteroids
Monoclonal Antibodies
Anti-cytokine Drug
Cytotoxic Drug
Market segment by Application
Eosinophilic Esophagitis
Eosinophilic Granulomatosis with Polyangiitis
Hyper-eosinophilic Syndrome
Nasal Polyposis
Other
Major players covered
Takeda Pharmaceutical Company Limited
Ellodi Pharmaceuticals
Bristol-Myers Squibb Company
AstraZeneca
GSK plc
Regeneron Pharmaceuticals Inc
Allakos Inc
Arena Pharmaceuticals Ltd
Revolo Biotherapeutics
DBV Technologies
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eosinophilic Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Eosinophilic Disease, with price, sales, revenue and global market share of Eosinophilic Disease from 2018 to 2023.
Chapter 3, the Eosinophilic Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eosinophilic Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Eosinophilic Disease market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Eosinophilic Disease.
Chapter 14 and 15, to describe Eosinophilic Disease sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Eosinophilic Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Eosinophilic Disease Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Corticosteroids
1.3.3 Monoclonal Antibodies
1.3.4 Anti-cytokine Drug
1.3.5 Cytotoxic Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Eosinophilic Disease Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Eosinophilic Esophagitis
1.4.3 Eosinophilic Granulomatosis with Polyangiitis
1.4.4 Hyper-eosinophilic Syndrome
1.4.5 Nasal Polyposis
1.4.6 Other
1.5 Global Eosinophilic Disease Market Size & Forecast
1.5.1 Global Eosinophilic Disease Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Eosinophilic Disease Sales Quantity (2018-2029)
1.5.3 Global Eosinophilic Disease Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Takeda Pharmaceutical Company Limited
2.1.1 Takeda Pharmaceutical Company Limited Details
2.1.2 Takeda Pharmaceutical Company Limited Major Business
2.1.3 Takeda Pharmaceutical Company Limited Eosinophilic Disease Product and Services
2.1.4 Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.2 Ellodi Pharmaceuticals
2.2.1 Ellodi Pharmaceuticals Details
2.2.2 Ellodi Pharmaceuticals Major Business
2.2.3 Ellodi Pharmaceuticals Eosinophilic Disease Product and Services
2.2.4 Ellodi Pharmaceuticals Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ellodi Pharmaceuticals Recent Developments/Updates
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business
2.3.3 Bristol-Myers Squibb Company Eosinophilic Disease Product and Services
2.3.4 Bristol-Myers Squibb Company Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Eosinophilic Disease Product and Services
2.4.4 AstraZeneca Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AstraZeneca Recent Developments/Updates
2.5 GSK plc
2.5.1 GSK plc Details
2.5.2 GSK plc Major Business
2.5.3 GSK plc Eosinophilic Disease Product and Services
2.5.4 GSK plc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GSK plc Recent Developments/Updates
2.6 Regeneron Pharmaceuticals Inc
2.6.1 Regeneron Pharmaceuticals Inc Details
2.6.2 Regeneron Pharmaceuticals Inc Major Business
2.6.3 Regeneron Pharmaceuticals Inc Eosinophilic Disease Product and Services
2.6.4 Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
2.7 Allakos Inc
2.7.1 Allakos Inc Details
2.7.2 Allakos Inc Major Business
2.7.3 Allakos Inc Eosinophilic Disease Product and Services
2.7.4 Allakos Inc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Allakos Inc Recent Developments/Updates
2.8 Arena Pharmaceuticals Ltd
2.8.1 Arena Pharmaceuticals Ltd Details
2.8.2 Arena Pharmaceuticals Ltd Major Business
2.8.3 Arena Pharmaceuticals Ltd Eosinophilic Disease Product and Services
2.8.4 Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Arena Pharmaceuticals Ltd Recent Developments/Updates
2.9 Revolo Biotherapeutics
2.9.1 Revolo Biotherapeutics Details
2.9.2 Revolo Biotherapeutics Major Business
2.9.3 Revolo Biotherapeutics Eosinophilic Disease Product and Services
2.9.4 Revolo Biotherapeutics Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Revolo Biotherapeutics Recent Developments/Updates
2.10 DBV Technologies
2.10.1 DBV Technologies Details
2.10.2 DBV Technologies Major Business
2.10.3 DBV Technologies Eosinophilic Disease Product and Services
2.10.4 DBV Technologies Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 DBV Technologies Recent Developments/Updates
2.11 Cipla Inc
2.11.1 Cipla Inc Details
2.11.2 Cipla Inc Major Business
2.11.3 Cipla Inc Eosinophilic Disease Product and Services
2.11.4 Cipla Inc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cipla Inc Recent Developments/Updates
2.12 Sun Pharmaceutical Industries Ltd
2.12.1 Sun Pharmaceutical Industries Ltd Details
2.12.2 Sun Pharmaceutical Industries Ltd Major Business
2.12.3 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product and Services
2.12.4 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Eosinophilic Disease Product and Services
2.13.4 Sanofi Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sanofi Recent Developments/Updates
3 Competitive Environment: Eosinophilic Disease by Manufacturer
3.1 Global Eosinophilic Disease Sales Quantity by Manufacturer (2018-2023)
3.2 Global Eosinophilic Disease Revenue by Manufacturer (2018-2023)
3.3 Global Eosinophilic Disease Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Eosinophilic Disease by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Eosinophilic Disease Manufacturer Market Share in 2022
3.4.2 Top 6 Eosinophilic Disease Manufacturer Market Share in 2022
3.5 Eosinophilic Disease Market: Overall Company Footprint Analysis
3.5.1 Eosinophilic Disease Market: Region Footprint
3.5.2 Eosinophilic Disease Market: Company Product Type Footprint
3.5.3 Eosinophilic Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Eosinophilic Disease Market Size by Region
4.1.1 Global Eosinophilic Disease Sales Quantity by Region (2018-2029)
4.1.2 Global Eosinophilic Disease Consumption Value by Region (2018-2029)
4.1.3 Global Eosinophilic Disease Average Price by Region (2018-2029)
4.2 North America Eosinophilic Disease Consumption Value (2018-2029)
4.3 Europe Eosinophilic Disease Consumption Value (2018-2029)
4.4 Asia-Pacific Eosinophilic Disease Consumption Value (2018-2029)
4.5 South America Eosinophilic Disease Consumption Value (2018-2029)
4.6 Middle East and Africa Eosinophilic Disease Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Eosinophilic Disease Sales Quantity by Type (2018-2029)
5.2 Global Eosinophilic Disease Consumption Value by Type (2018-2029)
5.3 Global Eosinophilic Disease Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Eosinophilic Disease Sales Quantity by Application (2018-2029)
6.2 Global Eosinophilic Disease Consumption Value by Application (2018-2029)
6.3 Global Eosinophilic Disease Average Price by Application (2018-2029)
7 North America
7.1 North America Eosinophilic Disease Sales Quantity by Type (2018-2029)
7.2 North America Eosinophilic Disease Sales Quantity by Application (2018-2029)
7.3 North America Eosinophilic Disease Market Size by Country
7.3.1 North America Eosinophilic Disease Sales Quantity by Country (2018-2029)
7.3.2 North America Eosinophilic Disease Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Eosinophilic Disease Sales Quantity by Type (2018-2029)
8.2 Europe Eosinophilic Disease Sales Quantity by Application (2018-2029)
8.3 Europe Eosinophilic Disease Market Size by Country
8.3.1 Europe Eosinophilic Disease Sales Quantity by Country (2018-2029)
8.3.2 Europe Eosinophilic Disease Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Eosinophilic Disease Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Eosinophilic Disease Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Eosinophilic Disease Market Size by Region
9.3.1 Asia-Pacific Eosinophilic Disease Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Eosinophilic Disease Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Eosinophilic Disease Sales Quantity by Type (2018-2029)
10.2 South America Eosinophilic Disease Sales Quantity by Application (2018-2029)
10.3 South America Eosinophilic Disease Market Size by Country
10.3.1 South America Eosinophilic Disease Sales Quantity by Country (2018-2029)
10.3.2 South America Eosinophilic Disease Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Eosinophilic Disease Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Eosinophilic Disease Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Eosinophilic Disease Market Size by Country
11.3.1 Middle East & Africa Eosinophilic Disease Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Eosinophilic Disease Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Eosinophilic Disease Market Drivers
12.2 Eosinophilic Disease Market Restraints
12.3 Eosinophilic Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Eosinophilic Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Eosinophilic Disease
13.3 Eosinophilic Disease Production Process
13.4 Eosinophilic Disease Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Eosinophilic Disease Typical Distributors
14.3 Eosinophilic Disease Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Eosinophilic Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Eosinophilic Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Pharmaceutical Company Limited Major Business
Table 5. Takeda Pharmaceutical Company Limited Eosinophilic Disease Product and Services
Table 6. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 8. Ellodi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Ellodi Pharmaceuticals Major Business
Table 10. Ellodi Pharmaceuticals Eosinophilic Disease Product and Services
Table 11. Ellodi Pharmaceuticals Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ellodi Pharmaceuticals Recent Developments/Updates
Table 13. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Company Major Business
Table 15. Bristol-Myers Squibb Company Eosinophilic Disease Product and Services
Table 16. Bristol-Myers Squibb Company Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bristol-Myers Squibb Company Recent Developments/Updates
Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca Eosinophilic Disease Product and Services
Table 21. AstraZeneca Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. AstraZeneca Recent Developments/Updates
Table 23. GSK plc Basic Information, Manufacturing Base and Competitors
Table 24. GSK plc Major Business
Table 25. GSK plc Eosinophilic Disease Product and Services
Table 26. GSK plc Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GSK plc Recent Developments/Updates
Table 28. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 29. Regeneron Pharmaceuticals Inc Major Business
Table 30. Regeneron Pharmaceuticals Inc Eosinophilic Disease Product and Services
Table 31. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 33. Allakos Inc Basic Information, Manufacturing Base and Competitors
Table 34. Allakos Inc Major Business
Table 35. Allakos Inc Eosinophilic Disease Product and Services
Table 36. Allakos Inc Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Allakos Inc Recent Developments/Updates
Table 38. Arena Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Arena Pharmaceuticals Ltd Major Business
Table 40. Arena Pharmaceuticals Ltd Eosinophilic Disease Product and Services
Table 41. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Arena Pharmaceuticals Ltd Recent Developments/Updates
Table 43. Revolo Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Revolo Biotherapeutics Major Business
Table 45. Revolo Biotherapeutics Eosinophilic Disease Product and Services
Table 46. Revolo Biotherapeutics Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Revolo Biotherapeutics Recent Developments/Updates
Table 48. DBV Technologies Basic Information, Manufacturing Base and Competitors
Table 49. DBV Technologies Major Business
Table 50. DBV Technologies Eosinophilic Disease Product and Services
Table 51. DBV Technologies Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. DBV Technologies Recent Developments/Updates
Table 53. Cipla Inc Basic Information, Manufacturing Base and Competitors
Table 54. Cipla Inc Major Business
Table 55. Cipla Inc Eosinophilic Disease Product and Services
Table 56. Cipla Inc Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cipla Inc Recent Developments/Updates
Table 58. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Sun Pharmaceutical Industries Ltd Major Business
Table 60. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product and Services
Table 61. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 63. Sanofi Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi Major Business
Table 65. Sanofi Eosinophilic Disease Product and Services
Table 66. Sanofi Eosinophilic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sanofi Recent Developments/Updates
Table 68. Global Eosinophilic Disease Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Eosinophilic Disease Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Eosinophilic Disease Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Eosinophilic Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Eosinophilic Disease Production Site of Key Manufacturer
Table 73. Eosinophilic Disease Market: Company Product Type Footprint
Table 74. Eosinophilic Disease Market: Company Product Application Footprint
Table 75. Eosinophilic Disease New Market Entrants and Barriers to Market Entry
Table 76. Eosinophilic Disease Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Eosinophilic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Eosinophilic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Eosinophilic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Eosinophilic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Eosinophilic Disease Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Eosinophilic Disease Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Eosinophilic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Eosinophilic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Eosinophilic Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Eosinophilic Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Eosinophilic Disease Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Eosinophilic Disease Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Eosinophilic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Eosinophilic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Eosinophilic Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Eosinophilic Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Eosinophilic Disease Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Eosinophilic Disease Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Eosinophilic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Eosinophilic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Eosinophilic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Eosinophilic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Eosinophilic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Eosinophilic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Eosinophilic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Eosinophilic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Eosinophilic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Eosinophilic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Eosinophilic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Eosinophilic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Eosinophilic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Eosinophilic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Eosinophilic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Eosinophilic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Eosinophilic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Eosinophilic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Eosinophilic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Eosinophilic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Eosinophilic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Eosinophilic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Eosinophilic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Eosinophilic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Eosinophilic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Eosinophilic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Eosinophilic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Eosinophilic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Eosinophilic Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Eosinophilic Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Eosinophilic Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Eosinophilic Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Eosinophilic Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Eosinophilic Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Eosinophilic Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Eosinophilic Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Eosinophilic Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Eosinophilic Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Eosinophilic Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Eosinophilic Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Eosinophilic Disease Raw Material
Table 136. Key Manufacturers of Eosinophilic Disease Raw Materials
Table 137. Eosinophilic Disease Typical Distributors
Table 138. Eosinophilic Disease Typical Customers
List of Figures
Figure 1. Eosinophilic Disease Picture
Figure 2. Global Eosinophilic Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Eosinophilic Disease Consumption Value Market Share by Type in 2022
Figure 4. Corticosteroids Examples
Figure 5. Monoclonal Antibodies Examples
Figure 6. Anti-cytokine Drug Examples
Figure 7. Cytotoxic Drug Examples
Figure 8. Global Eosinophilic Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Eosinophilic Disease Consumption Value Market Share by Application in 2022
Figure 10. Eosinophilic Esophagitis Examples
Figure 11. Eosinophilic Granulomatosis with Polyangiitis Examples
Figure 12. Hyper-eosinophilic Syndrome Examples
Figure 13. Nasal Polyposis Examples
Figure 14. Other Examples
Figure 15. Global Eosinophilic Disease Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Eosinophilic Disease Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Eosinophilic Disease Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Eosinophilic Disease Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Eosinophilic Disease Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Eosinophilic Disease Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Eosinophilic Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Eosinophilic Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Eosinophilic Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Eosinophilic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Eosinophilic Disease Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Eosinophilic Disease Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Eosinophilic Disease Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Eosinophilic Disease Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Eosinophilic Disease Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Eosinophilic Disease Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Eosinophilic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Eosinophilic Disease Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Eosinophilic Disease Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Eosinophilic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Eosinophilic Disease Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Eosinophilic Disease Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Eosinophilic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Eosinophilic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Eosinophilic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Eosinophilic Disease Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Eosinophilic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Eosinophilic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Eosinophilic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Eosinophilic Disease Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Eosinophilic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Eosinophilic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Eosinophilic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Eosinophilic Disease Consumption Value Market Share by Region (2018-2029)
Figure 57. China Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Eosinophilic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Eosinophilic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Eosinophilic Disease Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Eosinophilic Disease Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Eosinophilic Disease Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Eosinophilic Disease Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Eosinophilic Disease Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Eosinophilic Disease Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Eosinophilic Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Eosinophilic Disease Market Drivers
Figure 78. Eosinophilic Disease Market Restraints
Figure 79. Eosinophilic Disease Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Eosinophilic Disease in 2022
Figure 82. Manufacturing Process Analysis of Eosinophilic Disease
Figure 83. Eosinophilic Disease Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
